The transcriptional repressor Snail promotes mammary tumor recurrence

Global cancer statistics

2011 • 55,498 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

1987 • 11,429 citations

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2001 • 11,070 citations

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 • 10,602 citations

Gene expression profiling predicts clinical outcome of breast cancer

2002 • 9,314 citations

Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 • 5,356 citations

Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis

2004 • 3,727 citations

The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

2000 • 3,504 citations

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

2002 • 2,968 citations

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2005 • 2,658 citations

The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

2000 • 2,569 citations

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1989 • 2,245 citations

Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

2004 • 1,530 citations

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

1996 • 1,393 citations

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2005 • 1,225 citations

The SLUG zinc-finger protein represses E-cadherin in breast cancer.

2002 • 991 citations

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

2004 • 941 citations

Annual hazard rates of recurrence for breast cancer after primary therapy.

1996 • 833 citations

The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition

2001 • 611 citations

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

2002 • 577 citations

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1988 • 570 citations

Significance of ipsilateral breast tumour recurrence after lumpectomy

1991 • 556 citations

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1978 • 465 citations

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.

1993 • 398 citations

Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription

2005 • 373 citations

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

2004 • 358 citations

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis

2002 • 339 citations

Pak1 Phosphorylation of Snail, a Master Regulator of Epithelial-to-Mesenchyme Transition, Modulates Snail's Subcellular Localization and Functions

2005 • 265 citations

Prognostic molecular markers in early breast cancer

2004 • 245 citations

Local Failure Is Responsible for the Decrease in Survival for Patients With Breast Cancer Treated With Conservative Surgery and Postoperative Radiotherapy

1999 • 241 citations

The Akt Proto-oncogene Links Ras to Pak and Cell Survival Signals

2000 • 235 citations

Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene

2001 • 223 citations

Twist Function Is Required for the Morphogenesis of the Cephalic Neural Tube and the Differentiation of the Cranial Neural Crest Cells in the Mouse Embryo

2002 • 220 citations

A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology

2002 • 201 citations

Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.

2000 • 170 citations

Role of Isolated Locoregional Recurrence of Breast Cancer: Results of Four Prospective Studies

2000 • 147 citations

Long-term results of local recurrence after breast conservation treatment for invasive breast cancer

2001 • 133 citations

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

2003 • 130 citations

MUTATIONS AND CHROMOSOMAL REARRANGEMENTS AFFECTING THE EXPRESSION OF SNAIL, A GENE INVOLVED IN EMBRYONIC PATTERNING IN DROSOPHILA MELANOGASTER

1984 • 123 citations

Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer

2001 • 111 citations

Transgenic oncogene mice. Tumor phenotype predicts genotype.

1991 • 100 citations

Targeting HER2: Recent developments and future directions for breast cancer patients

2001 • 94 citations

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

2003 • 72 citations

The prognostic significance of epithelial-mesenchymal transition in breast cancer.

2003 • 70 citations

Targeting HER2: Recent developments and future directions for breast cancer patients

2001 • 70 citations

Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour

2004 • 67 citations

Natural History of More Than 20 Years of Node-Positive Primary Breast Carcinoma Treated With Cyclophosphamide, Methotrexate, and Fluorouracil–Based Adjuvant Chemotherapy: A Study by the Cancer and Leukemia Group B

2003 • 65 citations

E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.

1996 • 34 citations

Vimentin expression in breast carcinomas.

2003 • 12 citations